Farringdon Capital »

Adma Biologics shares owned by Farringdon Capital

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Farringdon Capital from 13F filings

Historical chart of Farringdon Capital investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Farringdon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Farringdon Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $167k 11k 14.66

More positions owned by Farringdon Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Short Treas Bd (SHV)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
S&p Global (SPGI)
Haleon Spon Ads (HLN)
Rentokil Initial Sponsored Adr (RTO)
Broadcom (AVGO)
Vaneck Bitcoin Etf Sh Ben Int (HODL)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Invesco Galaxy Bitcoin Etf Com Shs Ben Int (BTCO)
Ishares Ethereum Tr SHS (ETHA)
Grayscale Ethereum Mini Tr E Shs New (ETH)
Sprott Asset Management Physical Gold Tr (PHYS)
Capital One Financial (COF)

View all positions for Farringdon Capital

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics